- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Segment 8 - Cost of Care and Treatment
The panelists debate the costs of multiple myeloma treatment. There are costs for initial treatment, maintenance care, and the price that comes with taking multiple drugs.
The panelists debate the costs of multiple myeloma treatment. There are costs for initial treatment, maintenance care, and the price that comes with taking multiple drugs. It’s important that treatment is the “best at the beginning.”
In general, the disease is extremely expensive to treat, and there may be nearly 100,000 patients who suffer from the disease. Treatment can last for years, which only adds to costs.
Risk factors are also analyzed by the panel. Dr Kumar notes that some studies have shown African Americans and people who are obese may be at increased risk for developing the disease.
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Trastuzumab Deruxtecan Receives FDA Approval for HER2-Positive Solid Tumors
April 5th 2024FDA granted accelerated approval to trastuzumab deruxtecan-nxki for adult patients with unresectable or metastatic HER2-positive solid tumors who received prior systemic treatment and have no satisfactory alternative treatment options.
Read More
